Cornea

Microbial Keratitis

Unlock FRCOphth Part 2 Study Notes to access this content.

Get access

Risk factors

  • Trauma/abrasion
  • CL wear especially extended wear and with poor hygiene
  • Iatrogenic: suture removal, LASIK, topical therapy especially steroid
  • Ocular surface disease/exposure, blepharokeratoconjunctivitis
  • Lid disease: entropion/trichiasis
  • Nasolacrimal disease: chronic dacryocystitis
  • Immunosuppression
  • Nutritional: vitamin A deficiency

Complications

  • Limbal/scleral extension
  • Perforation
  • Endophthalmitis (eg. gonococcus, fungi or perforation)

Management

See Microbiology section for stains/culture media.

  • Admit if necessary
  • Identify risk factors (as above)
  • Perform corneal scrape

Sterilization phase

  • Admission and stop CLs

  • Intensive topical antibiotics: typically combined therapy with cephalosporin (eg. cefuroxime 5%) and fluoroquinolone (eg. moxifloxacin 0.5% which has superior ocular penetration or ofloxacin 0.3%) or gentamicin forte (1.5%). Hourly day and night instillation for 24-48 hours

    • Quinolone monotherapy is inadequate against resistant species of Staph and Pseudomonas
    • Prolonged use of fortified aminoglycoside is toxic to the epithelium and can lead to necrosis
  • Consider oral antibiotics (typically ciprofloxacin) if limbal disease, perforation or risk of endophthalmitis or bacterial scleritis

  • Oral tetracyclines (and vitamin C) can promote healing (inhibit MMPs and inflammatory cytokines)

  • Cycloplegia and oral analgesia for comfort

Healing phase

  • Taper therapy with improvement
  • Add lubricant
  • Add non-preserved topical steroid to reduce inflammation (typically only after re-epithelisation)
    • Steroids are contraindicated in fungal or mycobacterial cases (risk factors include previous refractive surgery and trauma involving vegetation)
    • Steroids can retard the eyes response to the microbes and retard epithelisation

Hot Topic

The Steroids for Clinical Ulcer Trial (SCUT): showed no effect on overall visual outcome but no apparent increased risk of perforation or safety issues

  • Where there are no positive microbiology results and initial treatment is ineffective, consider with-holding treatment and re-scraping (or corneal biopsy, PCR or confocal microscopy)
    • Restart intensive antibiotics
    • Consider alternative diagnoses eg sterile ulcer
    • Therapeutic penetrating keratoplasty
    • Gunderson flap for non-healing ulcers

Sterile ulcers

  • Post-infective eg. herpetic, fungal

  • Nearby ocular surface inflammation

    • Lids/lashes
    • Skin: SJS, OCP, rosacea
    • Lacrimal gland: sicca
  • Neurotrophic

    • Diabetes, herpetic
  • Exposure

    • Facial palsy
    • Lagophthalmos
    • Proptosis
  • Nutritional: vitamin A deficiency

  • Neoplasia: acute leukaemia

  • Immune-mediated

    • Connective tissues disease/PUK
    • Mooren’s
    • Marginal keratitis
    • Allergic keratitis
  • Iatrogenic/self-inflicted

Fungal keratitis

  • Filamentous (septate eg. Fusarium and Aspergillus, and non-septate) vs yeasts
  • Risk factors
    • Trauma with organic matter
    • Ocular surface disease
    • Systemic/local immunosuppression or steroids

Hot Topic

Always consider fungal keratitis in patients on long-term steroids

Features

  • Fluffy/feathery white ulcer
  • Satellite lesions
  • Ring infiltrate
  • Endothelial plaque

Management

  • Antifungals interfere with ergosterol metabolism
  • Amphoteracin B 0.015% is a polyene (yeasts)
  • Natamycin 5% (filamentous)
  • Azoles can be used systemically but are toxic
  • Topical voriconazole 0.1%

Persistent epithelial defect

  • Remember that drug toxicity may cause symptoms even after the infection is eradicated
  • Defined as a defect for >2 weeks
  • Use non-preserved preparations
  • Reduce frequency of therapy
  • Add lubricant
  • Ocular surface protection: tarsorrhaphy

Perforation

  • Causes
    • Infectious:

      • Diphtheria and gonococcus can cause extremely rapid onset perforation due to their virulence
      • Shigella, Listeria, and Haemophilus aegyptus also classical penetrate intact corneal epithelium
    • Surface related

    • Autoimmune: eg collagen vascular diseases like RA, SLE, GPA, sarcoid and IBD

    • Other: Moorens

Management

  • Therapeutic contact lenses: if no tissue loss or very small. Use with PF antibiotics
  • Corneal glue: if less than 2mm. Used with polythene patches and hydrogel contact lenses to reduce discomfort.
  • Amniotic membrane: for larger perforations. Provides biologically active anti-inflammatory and anti-scarring mediators
  • Lamellar or full-thickness keratoplasty reconstructions for larger perforations

Was this page helpful?

Previous
Corneal Physiology